Experimental cancer drug may boost Covid immune response, study finds
Researchers say the antiviral triggers ‘highly effective’ immune response to string of respiratory diseases

An experimental cancer drug derived from a poisonous plant could be used to boost the body’s natural immune response to Covid-19, new research suggests.
The antiviral, called thapsigargin, is being trialled as a treatment for prostate cancer patients. But scientists at the University of Nottingham believe the drug, derived from a Mediterranean weed that is highly toxic to sheep and cattle, may also be used to fight the coronavirus.
In what the team describe as a “ground-breaking study”, small doses of the antiviral were found to trigger a “highly effective” immune response against three types of human respiratory viruses including Sars-CoV-2, which causes Covid.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Study leader Professor Kin-Chow Chang said that the “hugely significant” findings “strongly indicate” that “thapsigargin and its derivatives are promising antiviral treatments against Covid and influenza” - and also “have the potential to defend us against the next Disease X pandemic”.
“A new generation of antivirals, such as thapsigargin, could play a key role in the control and treatment of important viral infections in both humans and animals,” he added.
Chang admits that more testing is “clearly needed”, with the Daily Mail noting that “no evidence exists that it will work on humans”.
However, the research conducted so far has found that thapsigargin is “effective at blocking symptoms when used before or during active infection in petri dish tests and on mice”, the newspaper reports.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Chas Newkey-Burden has been part of The Week Digital team for more than a decade and a journalist for 25 years, starting out on the irreverent football weekly 90 Minutes, before moving to lifestyle magazines Loaded and Attitude. He was a columnist for The Big Issue and landed a world exclusive with David Beckham that became the weekly magazine’s bestselling issue. He now writes regularly for The Guardian, The Telegraph, The Independent, Metro, FourFourTwo and the i new site. He is also the author of a number of non-fiction books.
-
How to create a healthy 'germier' home
Under The Radar Exposure to a broad range of microbes can enhance our immune system, especially during childhood
-
George Floyd: Did Black Lives Matter fail?
Feature The momentum for change fades as the Black Lives Matter Plaza is scrubbed clean
-
National debt: Why Congress no longer cares
Feature Rising interest rates, tariffs and Trump's 'big, beautiful' bill could sent the national debt soaring
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
RFK Jr.: A new plan for sabotaging vaccines
Feature The Health Secretary announced changes to vaccine testing and asks Americans to 'do your own research'
-
The Y chromosome degrades over time. And men's health is paying for it
Under the radar The chromosome loss is linked to cancer and Alzheimer's
-
A bacterial toxin could be contributing to the colorectal cancer rise in young people
Under the radar Most exposure occurs in childhood
-
Five years on: How Covid changed everything
Feature We seem to have collectively forgotten Covid’s horrors, but they have completely reshaped politics
-
Why are more young people getting bowel cancer?
The Explainer Alarming rise in bowel-cancer diagnoses in under-50s is puzzling scientists
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter